\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ pending\ \(213\)\
\-\ \\â\\€\\¢\\ enhancing\\ mass\\ centered\\ in\\ pineal\\ region\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mass\\ demonstrates\\ mild\\ increase\\ in\\ signal\\ on\\ dwi\\ images\\ and\\ corresponding\\ low\\ signal\\ on\\ adc\\ map\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mass\\ causes\\ lateral\\ and\\ third\\ ventricular\\ hydrocephalus\\.\ \(0\)\
\-\ non\\-hodgkin\\'s\\ lymphoma\\ \\-\\ b\\-cell\\ lymphoma\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ pineal\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ 69\\ year\\ old\\ woman\\ with\\ a\\ one\\ month\\ history\\ of\\ headache\\,\\ diplopia\\,\\ ataxic\\ gait\\ and\\ visual\\ problem\\.\\ \\ previously\\ treated\\ for\\ non\\-hogdkins\\ lymphoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lymphoma\\:\\ 0\\.36584971169555136\ \(0\)\
\-\ pineal\\:\\ 0\\.3386423950406235\ \(0\)\
\-\ ataxic\\:\\ 0\\.20226777567747972\ \(0\)\
\-\ mass\\:\\ 0\\.17598273838127346\ \(0\)\
\-\ map\\:\\ 0\\.17454828096975172\ \(0\)\
\-\ signal\\:\\ 0\\.17411271020634714\ \(0\)\
\-\ 69\\:\\ 0\\.16118316817829625\ \(0\)\
\-\ diplopia\\:\\ 0\\.1606041764344945\ \(0\)\
\-\ centered\\:\\ 0\\.16003737490074268\ \(0\)\
\-\ adc\\:\\ 0\\.15840523407709797\ \(0\)\
\-\ problem\\:\\ 0\\.1514639385735961\ \(0\)\
\-\ dwi\\:\\ 0\\.14595044733325502\ \(0\)\
\-\ corresponding\\:\\ 0\\.14371893925465623\ \(0\)\
\-\ gait\\:\\ 0\\.13300770743255935\ \(0\)\
\-\ visual\\:\\ 0\\.13102725022912706\ \(0\)\
\-\ ventricular\\:\\ 0\\.1291825508567829\ \(0\)\
\-\ pending\\:\\ 0\\.12631039200223057\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.12536566073787783\ \(0\)\
\-\ increase\\:\\ 0\\.12328225091018719\ \(0\)\
\-\ previously\\:\\ 0\\.12328225091018719\ \(0\)\
\-\ third\\:\\ 0\\.11693325185964595\ \(0\)\
\-\ causes\\:\\ 0\\.11604318473272388\ \(0\)\
\-\ meningioma\\:\\ 0\\.11507582036200645\ \(0\)\
\-\ headache\\:\\ 0\\.10586688535243571\ \(0\)\
\-\ enhancing\\:\\ 0\\.09620452779228092\ \(0\)\
\-\ treated\\:\\ 0\\.09563445285850862\ \(0\)\
\-\ and\\:\\ 0\\.09520214602269754\ \(0\)\
\-\ month\\:\\ 0\\.09342043232741341\ \(0\)\
\-\ on\\:\\ 0\\.09276356405433665\ \(0\)\
\-\ region\\:\\ 0\\.09186062533247553\ \(0\)\
\-\ low\\:\\ 0\\.08812120887404243\ \(0\)\
\-\ one\\:\\ 0\\.08792794114931898\ \(0\)\
\-\ mild\\:\\ 0\\.08705635510317357\ \(0\)\
\-\ metastatic\\:\\ 0\\.0842272897092239\ \(0\)\
\-\ tumor\\:\\ 0\\.08032776239710297\ \(0\)\
\-\ woman\\:\\ 0\\.07998149294919565\ \(0\)\
\-\ demonstrates\\:\\ 0\\.07715357156000263\ \(0\)\
\-\ in\\:\\ 0\\.07640812136750026\ \(0\)\
\-\ lateral\\:\\ 0\\.07621507153706994\ \(0\)\
\-\ images\\:\\ 0\\.071037890008192\ \(0\)\
\-\ disease\\:\\ 0\\.06446462864853841\ \(0\)\
\-\ history\\:\\ 0\\.05867390294042007\ \(0\)\
\-\ year\\:\\ 0\\.047328277035263704\ \(0\)\
\-\ for\\:\\ 0\\.046546898021186285\ \(0\)\
\-\ old\\:\\ 0\\.04545152904352109\ \(0\)\
\-\ with\\:\\ 0\\.03007157817397129\ \(0\)\
\-\ of\\:\\ 0\\.030053621142500028\ \(0\)\
